维普中文期刊产品整合服务
8篇 您的检索式:作者名="Tetef ML"
    题名 作者 年代 出处 被引量
1Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis显示文摘Tetef ML Margolin KA Doroshow JH 2000Cancer Chemother Pharmacol2000,46,:1
2Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis显示文摘Tetef ML Margolin KA Doroshow JH 2000Cancer Chemother Pharmacol2000,46,:1
3Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis显示文摘Tetef ML Margolin KA Doroshow JH 2000Cancer Chemother Pharmacol2000,46,1:1
4Pharmacokinetics and toxicity of high-dose intrabenousis显示文摘Tetef ML Margolin KA Doroshow JH 2000Cancer Chemother Pharmacol2000,46,1:1
5Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis显示文摘Tetef ML Margolin KA Doroshow JH 2000Cancer Chemother Pharmacol2000,46,1:1
6Pharmacokinetics and toxicity of high-dose intravenousmethotrexate in the treatment of leptomeningealcarcinomatosis 显示文摘Tetef ML Margolin KA Doroshow JH 2000Cancer Chemother Pharmacol2000,46,1:1
7Phase Ⅰ trial of 96 - hour continuous infusion of dexrazoxane in patients with advanced malignancies显示文摘Tetef ML Synold TW Chow W 2001Clin Cancer Res2001,7,6:1
8Pharmaeokinetics and toxicity of high- dose intravenous methotrexate in the treatment of leptomeniageal carcinomatosis 显示文摘Tetef ML Margolin KA 2000Cancer Chemother Pharmacol2000,46,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费